154 related articles for article (PubMed ID: 26319488)
1. The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.
Samson P; Patel A; Robinson CG; Morgensztern D; Chang SH; Colditz GA; Waqar S; Crabtree TD; Krupnick AS; Kreisel D; Patterson GA; Meyers BF; Puri V
Ann Thorac Surg; 2015 Dec; 100(6):2026-32; discussion 2032. PubMed ID: 26319488
[TBL] [Abstract][Full Text] [Related]
2. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
[TBL] [Abstract][Full Text] [Related]
3. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
Kwan SW; Mortell KE; Hippe DS; Brunner MC
J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
Shah A; Hahn SM; Stetson RL; Friedberg JS; Pechet TT; Sher DJ
Cancer; 2013 Sep; 119(17):3123-32. PubMed ID: 23720093
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults.
Smith BD; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Shirvani SM
J Geriatr Oncol; 2015 Jul; 6(4):324-31. PubMed ID: 26094172
[TBL] [Abstract][Full Text] [Related]
6. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
[TBL] [Abstract][Full Text] [Related]
7. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more?
Alexander ES; Machan JT; Ng T; Breen LD; DiPetrillo TA; Dupuy DE
J Vasc Interv Radiol; 2013 Apr; 24(4):476-82. PubMed ID: 23462066
[TBL] [Abstract][Full Text] [Related]
8. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.
Broderick SR; Patel AP; Crabtree TD; Bell JM; Morgansztern D; Robinson CG; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
Ann Thorac Surg; 2016 Feb; 101(2):451-7; discussion 457-8. PubMed ID: 26410162
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness and lung cancer clinical trials.
Du W; Reeves JH; Gadgeel S; Abrams J; Peters WP
Cancer; 2003 Oct; 98(7):1491-6. PubMed ID: 14508837
[TBL] [Abstract][Full Text] [Related]
10. Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
Wang YT; Huang G
Eur J Radiol; 2012 Aug; 81(8):e903-9. PubMed ID: 22698711
[TBL] [Abstract][Full Text] [Related]
11. Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis.
Ferguson MK
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1935-42. PubMed ID: 14688709
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?
Samson P; Patel A; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
Ann Thorac Surg; 2015 Nov; 100(5):1773-9. PubMed ID: 26228601
[TBL] [Abstract][Full Text] [Related]
13. Cost of combined modality interventions for stage III non-small-cell lung cancer.
Evans WK; Will BP; Berthelot JM; Earle CC
J Clin Oncol; 1997 Sep; 15(9):3038-48. PubMed ID: 9294466
[TBL] [Abstract][Full Text] [Related]
14. Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.
Buck PO; Saverno KR; Miller PJ; Arondekar B; Walker MS
Clin Lung Cancer; 2015 Nov; 16(6):486-95. PubMed ID: 25681298
[TBL] [Abstract][Full Text] [Related]
15. Initial and Longitudinal Cost of Surgical Resection for Lung Cancer.
Cowper PA; Feng L; Kosinski AS; Tong BC; Habib RH; Putnam JB; Onaitis MW; Furnary AP; Wright CD; Jacobs JP; Fernandez FG
Ann Thorac Surg; 2021 Jun; 111(6):1827-1833. PubMed ID: 33031776
[TBL] [Abstract][Full Text] [Related]
16. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
[TBL] [Abstract][Full Text] [Related]
17. Cost and quality of life in thoracic surgery--a health economic analysis in a German center.
Welcker K; Marian P; Thetter O; Siebeck M
Thorac Cardiovasc Surg; 2003 Oct; 51(5):260-6. PubMed ID: 14571342
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers.
Porter GA; Cantor SB; Walsh GL; Rusch VW; Leung DH; DeJesus AY; Pollock RE; Brennan MF; Pisters PW
J Thorac Cardiovasc Surg; 2004 May; 127(5):1366-72. PubMed ID: 15115994
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
20. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.
Stenehjem DD; Bellows BK; Yager KM; Jones J; Kaldate R; Siebert U; Brixner DI
Oncologist; 2016 Feb; 21(2):196-204. PubMed ID: 26614710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
